Cancer Cell, ISSN 1535-6108, 2007, Volume 12, Issue 2, pp. 171 - 185
Cancer cells exhibit many abnormal phenotypes that induce apoptotic signaling via the intrinsic, or mitochondrial, pathway. That cancer cells nonetheless...
CELLCYCLE | MITOCHONDRIAL-MEMBRANE PERMEABILIZATION | B-CELL LYMPHOMA | ONCOLOGY | PROTOTYPE CANCER THERAPEUTICS | CHROMOSOMAL BREAKPOINT | FOLLICULAR LYMPHOMA | INDUCE APOPTOSIS | CYTOCHROME-C RELEASE | BCL-2 FAMILY-MEMBERS | BH3-ONLY PROTEINS | ANTIAPOPTOTIC BCL-2 | Vincristine - pharmacology | Immunoprecipitation | Proto-Oncogene Proteins c-bcl-2 - physiology | Antibiotics, Antineoplastic - pharmacology | Apoptosis - drug effects | Humans | Immunoblotting | Lymphoma, B-Cell - genetics | Bcl-2-Like Protein 11 | Biphenyl Compounds - pharmacology | Nitrophenols - pharmacology | Apoptosis Regulatory Proteins - genetics | Membrane Proteins - metabolism | BH3 Interacting Domain Death Agonist Protein - metabolism | Lymphoma, B-Cell - drug therapy | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Membrane Proteins - genetics | Tumor Cells, Cultured - drug effects | Etoposide - pharmacology | Proto-Oncogene Proteins - genetics | Sulfonamides - pharmacology | Piperazines - pharmacology | Blotting, Western | Apoptosis Regulatory Proteins - metabolism | Membrane Proteins - antagonists & inhibitors | Apoptosis Regulatory Proteins - antagonists & inhibitors | Lymphoma, B-Cell - pathology | Apoptosis Regulatory Proteins - physiology | Antineoplastic Agents, Phytogenic - pharmacology | Lymphoma, Large B-Cell, Diffuse - genetics | Doxorubicin - pharmacology
CELLCYCLE | MITOCHONDRIAL-MEMBRANE PERMEABILIZATION | B-CELL LYMPHOMA | ONCOLOGY | PROTOTYPE CANCER THERAPEUTICS | CHROMOSOMAL BREAKPOINT | FOLLICULAR LYMPHOMA | INDUCE APOPTOSIS | CYTOCHROME-C RELEASE | BCL-2 FAMILY-MEMBERS | BH3-ONLY PROTEINS | ANTIAPOPTOTIC BCL-2 | Vincristine - pharmacology | Immunoprecipitation | Proto-Oncogene Proteins c-bcl-2 - physiology | Antibiotics, Antineoplastic - pharmacology | Apoptosis - drug effects | Humans | Immunoblotting | Lymphoma, B-Cell - genetics | Bcl-2-Like Protein 11 | Biphenyl Compounds - pharmacology | Nitrophenols - pharmacology | Apoptosis Regulatory Proteins - genetics | Membrane Proteins - metabolism | BH3 Interacting Domain Death Agonist Protein - metabolism | Lymphoma, B-Cell - drug therapy | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Membrane Proteins - genetics | Tumor Cells, Cultured - drug effects | Etoposide - pharmacology | Proto-Oncogene Proteins - genetics | Sulfonamides - pharmacology | Piperazines - pharmacology | Blotting, Western | Apoptosis Regulatory Proteins - metabolism | Membrane Proteins - antagonists & inhibitors | Apoptosis Regulatory Proteins - antagonists & inhibitors | Lymphoma, B-Cell - pathology | Apoptosis Regulatory Proteins - physiology | Antineoplastic Agents, Phytogenic - pharmacology | Lymphoma, Large B-Cell, Diffuse - genetics | Doxorubicin - pharmacology
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2007, Volume 104, Issue 32, pp. 13134 - 13139
Classical Hodgkin lymphomas (cHLs) contain small numbers of neoplastic Reed-Sternberg (RS) cells within an extensive inflammatory infiltrate that includes...
T lymphocytes | Reed Sternberg cells | Tumor cell line | Cytokines | Cell lines | Coculture techniques | Lymphoma | Viability | Application programming interfaces | Tumors | c-Jun | Microenvironment | Immunomodulation | Th2 | TARGET | immunomodulation | APOPTOSIS | MULTIDISCIPLINARY SCIENCES | DEATH | SUPPRESSION | T-reg | microenvironment | FALSE DISCOVERY RATE | DISEASE | REGULATORY T-CELLS | GENE-EXPRESSION | INFLAMMATORY RESPONSE | PROMOTER | Evaluation | Immunology | Physiological aspects | Genetic aspects | Research | T cells | Binding proteins | Hodgkin's disease
T lymphocytes | Reed Sternberg cells | Tumor cell line | Cytokines | Cell lines | Coculture techniques | Lymphoma | Viability | Application programming interfaces | Tumors | c-Jun | Microenvironment | Immunomodulation | Th2 | TARGET | immunomodulation | APOPTOSIS | MULTIDISCIPLINARY SCIENCES | DEATH | SUPPRESSION | T-reg | microenvironment | FALSE DISCOVERY RATE | DISEASE | REGULATORY T-CELLS | GENE-EXPRESSION | INFLAMMATORY RESPONSE | PROMOTER | Evaluation | Immunology | Physiological aspects | Genetic aspects | Research | T cells | Binding proteins | Hodgkin's disease
Journal Article
Blood, ISSN 0006-4971, 10/2010, Volume 116, Issue 17, pp. 3268 - 3277
Classical Hodgkin lymphoma (cHL) and mediastinal large B-cell lymphoma (MLBCL) are lymphoid malignancies with certain shared clinical, histologic, and...
GALECTIN-1 | RESPONSES | IFN-GAMMA | PANCREATIC-CANCER | COSTIMULATORY MOLECULE | IMBALANCES | B7-H1 | HEMATOLOGY | CARCINOMA | CIRCULAR BINARY SEGMENTATION | CLINICAL-SIGNIFICANCE | Cell Proliferation | B7-H1 Antigen | Hodgkin Disease - genetics | Humans | Programmed Cell Death 1 Ligand 2 Protein | Gene Expression Regulation, Neoplastic | Intercellular Signaling Peptides and Proteins - genetics | Janus Kinase 2 - genetics | Gene Dosage | Gene Expression Profiling | Antigens, CD - genetics | Chromosomes, Human, Pair 9 - genetics | Janus Kinase 2 - metabolism | Cell Line, Tumor | Tumor Cells, Cultured | Lymphoma, Large B-Cell, Diffuse - genetics | Janus Kinase 2 - antagonists & inhibitors | Lymphoid Neoplasia
GALECTIN-1 | RESPONSES | IFN-GAMMA | PANCREATIC-CANCER | COSTIMULATORY MOLECULE | IMBALANCES | B7-H1 | HEMATOLOGY | CARCINOMA | CIRCULAR BINARY SEGMENTATION | CLINICAL-SIGNIFICANCE | Cell Proliferation | B7-H1 Antigen | Hodgkin Disease - genetics | Humans | Programmed Cell Death 1 Ligand 2 Protein | Gene Expression Regulation, Neoplastic | Intercellular Signaling Peptides and Proteins - genetics | Janus Kinase 2 - genetics | Gene Dosage | Gene Expression Profiling | Antigens, CD - genetics | Chromosomes, Human, Pair 9 - genetics | Janus Kinase 2 - metabolism | Cell Line, Tumor | Tumor Cells, Cultured | Lymphoma, Large B-Cell, Diffuse - genetics | Janus Kinase 2 - antagonists & inhibitors | Lymphoid Neoplasia
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 10/2005, Volume 280, Issue 40, pp. 33756 - 33765
BAL1 ( B - a ggressive l ymphoma 1 ) was originally identified as a risk-related gene in diffuse large B-cell lymphoma. BAL1 encodes a nuclear protein with...
CELLS | HISTONE MACROH2A | COREPRESSOR | GENE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CRYSTAL-STRUCTURES | CORE HISTONE | PARP | IDENTIFICATION | INACTIVE X-CHROMOSOME | BINDING | Protein Structure, Tertiary | Amino Acid Sequence | Chromatin - metabolism | Promoter Regions, Genetic | Humans | Neoplasm Proteins - physiology | Molecular Sequence Data | Structure-Activity Relationship | Lymphoma, B-Cell - genetics | Sequence Analysis, DNA | Poly(ADP-ribose) Polymerases - metabolism | Transcription, Genetic - physiology | Cloning, Molecular | Protein Processing, Post-Translational | Neoplasm Proteins - genetics | DNA, Complementary
CELLS | HISTONE MACROH2A | COREPRESSOR | GENE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CRYSTAL-STRUCTURES | CORE HISTONE | PARP | IDENTIFICATION | INACTIVE X-CHROMOSOME | BINDING | Protein Structure, Tertiary | Amino Acid Sequence | Chromatin - metabolism | Promoter Regions, Genetic | Humans | Neoplasm Proteins - physiology | Molecular Sequence Data | Structure-Activity Relationship | Lymphoma, B-Cell - genetics | Sequence Analysis, DNA | Poly(ADP-ribose) Polymerases - metabolism | Transcription, Genetic - physiology | Cloning, Molecular | Protein Processing, Post-Translational | Neoplasm Proteins - genetics | DNA, Complementary
Journal Article
Critical Care, ISSN 1364-8535, 06/2019, Volume 23, Issue 1, pp. 202 - 202
Background: Rapid detection, early resuscitation, and appropriate antibiotic use are crucial for sepsis care. Accurate identification of the site of infection...
Infection | Sepsis | Diagnosis | Source | IMPACT | ANTIBIOTICS | THERAPY | SEPTIC SHOCK | ADULTS | CRITICAL CARE MEDICINE | Usage | Antibiotics | Patient outcomes | Mortality | Diagnostic errors | Evidence-based medicine | Ventilators | Intensive care | Critical care | Infections | Emergency medical care | Vital signs | Patients | Abdomen | Data collection | Urogenital system | Index Medicus
Infection | Sepsis | Diagnosis | Source | IMPACT | ANTIBIOTICS | THERAPY | SEPTIC SHOCK | ADULTS | CRITICAL CARE MEDICINE | Usage | Antibiotics | Patient outcomes | Mortality | Diagnostic errors | Evidence-based medicine | Ventilators | Intensive care | Critical care | Infections | Emergency medical care | Vital signs | Patients | Abdomen | Data collection | Urogenital system | Index Medicus
Journal Article
Cancer Cell, ISSN 1535-6108, 09/2012, Volume 22, Issue 3, pp. 359 - 372
Diffuse large B cell lymphoma (DLBCL) is a clinically and biologically heterogeneous disease with a high proliferation rate. By integrating copy number data...
GENOMIC INSTABILITY | INACTIVATION | MESSENGER-RNA TRANSLATION | INHIBITION | ONCOLOGY | R-CHOP | GENE-EXPRESSION | PROGNOSTIC-SIGNIFICANCE | ARGININE METHYLATION | COPY NUMBER VARIATION | CANCER | CELL BIOLOGY | Cell Cycle - genetics | Cell Proliferation | E2F Transcription Factors - biosynthesis | Lymphoma, Large B-Cell, Diffuse - pathology | Humans | Tumor Suppressor Protein p53 - metabolism | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Molecular Sequence Data | Gene Expression Profiling | Lymphoma, Large B-Cell, Diffuse - metabolism | Genes, p16 | Tumor Suppressor Protein p53 - genetics | DNA Copy Number Variations | Genes, p53 | Ki-67 Antigen - biosynthesis | E2F Transcription Factors - genetics | Lymphoma, Large B-Cell, Diffuse - genetics | Lymphomas | Tumor proteins | Analysis | Genes | Cell cycle
GENOMIC INSTABILITY | INACTIVATION | MESSENGER-RNA TRANSLATION | INHIBITION | ONCOLOGY | R-CHOP | GENE-EXPRESSION | PROGNOSTIC-SIGNIFICANCE | ARGININE METHYLATION | COPY NUMBER VARIATION | CANCER | CELL BIOLOGY | Cell Cycle - genetics | Cell Proliferation | E2F Transcription Factors - biosynthesis | Lymphoma, Large B-Cell, Diffuse - pathology | Humans | Tumor Suppressor Protein p53 - metabolism | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Molecular Sequence Data | Gene Expression Profiling | Lymphoma, Large B-Cell, Diffuse - metabolism | Genes, p16 | Tumor Suppressor Protein p53 - genetics | DNA Copy Number Variations | Genes, p53 | Ki-67 Antigen - biosynthesis | E2F Transcription Factors - genetics | Lymphoma, Large B-Cell, Diffuse - genetics | Lymphomas | Tumor proteins | Analysis | Genes | Cell cycle
Journal Article
Pediatrics International, ISSN 1328-8067, 11/2018, Volume 60, Issue 11, pp. 1045 - 1046
Journal Article
Blood, ISSN 0006-4971, 04/2011, Volume 117, Issue 16, pp. 4315 - 4322
Posttransplant lymphoproliferative disorders (PTLDs) are potentially fatal, EBV-driven B-cell malignancies that develop in immunocompromised solid organ or...
GLYCAN INTERACTIONS | IMMUNE PRIVILEGE | CLASSICAL HODGKIN | HODGKIN LYMPHOMA | C-JUN | HEMATOLOGY | B-CELL-LYMPHOMA | NF-KAPPA-B | EPSTEIN-BARR-VIRUS | STERNBERG CELLS | LATENT MEMBRANE PROTEIN-1 | Up-Regulation | Galectin 1 - immunology | Herpesvirus 4, Human - physiology | Humans | Lymphoproliferative Disorders - virology | Gene Expression Regulation, Neoplastic | Galectin 1 - genetics | Lymphoproliferative Disorders - genetics | Transcription Factor AP-1 - metabolism | Animals | Cell Line, Tumor | Viral Matrix Proteins - metabolism | Mice | T-Lymphocytes, Cytotoxic - cytology | Antibodies, Monoclonal - immunology | Cell Line, Transformed | Cell Transformation, Viral | Apoptosis
GLYCAN INTERACTIONS | IMMUNE PRIVILEGE | CLASSICAL HODGKIN | HODGKIN LYMPHOMA | C-JUN | HEMATOLOGY | B-CELL-LYMPHOMA | NF-KAPPA-B | EPSTEIN-BARR-VIRUS | STERNBERG CELLS | LATENT MEMBRANE PROTEIN-1 | Up-Regulation | Galectin 1 - immunology | Herpesvirus 4, Human - physiology | Humans | Lymphoproliferative Disorders - virology | Gene Expression Regulation, Neoplastic | Galectin 1 - genetics | Lymphoproliferative Disorders - genetics | Transcription Factor AP-1 - metabolism | Animals | Cell Line, Tumor | Viral Matrix Proteins - metabolism | Mice | T-Lymphocytes, Cytotoxic - cytology | Antibodies, Monoclonal - immunology | Cell Line, Transformed | Cell Transformation, Viral | Apoptosis
Journal Article
Blood, ISSN 0006-4971, 11/2006, Volume 108, Issue 10, pp. 3428 - 3433
The strength and duration of B-cell-receptor (BCR) signaling depends upon the balance between protein tyrosine kinase (PTK) activation and protein tyrosine...
BCR | LOCALIZATION | MACROPHAGES | ACUTE LYMPHOBLASTIC-LEUKEMIA | ANTIGEN-RECEPTOR | KINASE | TUMOR-SUPPRESSOR GENE | MOLECULAR-CLONING | IDENTIFICATION | HEMATOLOGY | EXPRESSION | Phosphorylation | Cell Proliferation | Signal Transduction | Protein-Tyrosine Kinases - metabolism | Humans | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Receptors, Antigen, B-Cell | Intracellular Signaling Peptides and Proteins - metabolism | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | Protein Tyrosine Phosphatases - genetics | Cell Line, Tumor | Lymphoma - pathology | Receptors, Cell Surface - physiology | Syk Kinase | Apoptosis | Protein Tyrosine Phosphatases - physiology | Protein-Tyrosine Kinases - antagonists & inhibitors | Receptors, Cell Surface - genetics
BCR | LOCALIZATION | MACROPHAGES | ACUTE LYMPHOBLASTIC-LEUKEMIA | ANTIGEN-RECEPTOR | KINASE | TUMOR-SUPPRESSOR GENE | MOLECULAR-CLONING | IDENTIFICATION | HEMATOLOGY | EXPRESSION | Phosphorylation | Cell Proliferation | Signal Transduction | Protein-Tyrosine Kinases - metabolism | Humans | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Receptors, Antigen, B-Cell | Intracellular Signaling Peptides and Proteins - metabolism | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | Protein Tyrosine Phosphatases - genetics | Cell Line, Tumor | Lymphoma - pathology | Receptors, Cell Surface - physiology | Syk Kinase | Apoptosis | Protein Tyrosine Phosphatases - physiology | Protein-Tyrosine Kinases - antagonists & inhibitors | Receptors, Cell Surface - genetics
Journal Article
Cancer Science, ISSN 1347-9032, 06/2013, Volume 104, Issue 6, pp. 773 - 778
The Japan National Committee for the Union for International Cancer Control (UICC) and UICC‐Asia Regional Office (ARO) organized an international session as...
ONCOLOGY | Delivery of Health Care - economics | Neoplasms - economics | Asia | Humans | United Nations | Health care industry | Cancer
ONCOLOGY | Delivery of Health Care - economics | Neoplasms - economics | Asia | Humans | United Nations | Health care industry | Cancer
Journal Article
Journal of Ultrasound in Medicine, ISSN 0278-4297, 11/2015, Volume 34, Issue 11, pp. 1969 - 1976
Objectives-This study was performed to evaluate the diagnostic utility of quantitative analysis of benign and malignant breast lesions using contrast-enhanced...
Contrast-enhanced sonography | Breast lesions | Kinetic parameters | Receiver operating characteristic curve | Breast ultrasound | Quantitative analysis | breast ultrasound | receiver operating characteristic curve | TUMORS | kinetic parameters | AGENT | ACOUSTICS | THERAPY | ULTRASOUND | breast lesions | contrast-enhanced sonography | COLOR DOPPLER US | EXPERIENCE | quantitative analysis | ULTRASONOGRAPHY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Diagnosis, Differential | Reproducibility of Results | Ultrasonography, Mammary - methods | Humans | Image Interpretation, Computer-Assisted - methods | Middle Aged | Male | Oxides | Iron | Ferric Compounds | Algorithms | Contrast Media | Sensitivity and Specificity | Adult | Female | Aged | Image Enhancement - methods | Breast Neoplasms - diagnostic imaging | Observer Variation | Pattern Recognition, Automated - methods
Contrast-enhanced sonography | Breast lesions | Kinetic parameters | Receiver operating characteristic curve | Breast ultrasound | Quantitative analysis | breast ultrasound | receiver operating characteristic curve | TUMORS | kinetic parameters | AGENT | ACOUSTICS | THERAPY | ULTRASOUND | breast lesions | contrast-enhanced sonography | COLOR DOPPLER US | EXPERIENCE | quantitative analysis | ULTRASONOGRAPHY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Diagnosis, Differential | Reproducibility of Results | Ultrasonography, Mammary - methods | Humans | Image Interpretation, Computer-Assisted - methods | Middle Aged | Male | Oxides | Iron | Ferric Compounds | Algorithms | Contrast Media | Sensitivity and Specificity | Adult | Female | Aged | Image Enhancement - methods | Breast Neoplasms - diagnostic imaging | Observer Variation | Pattern Recognition, Automated - methods
Journal Article
Pediatrics International, ISSN 1328-8067, 11/2018, Volume 60, Issue 11, pp. 1045 - 1046
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2000, Volume 6, Issue 10, pp. 4091 - 4095
Several genetic polymorphisms in metabolic activation or detoxification enzymes have been associated with susceptibility to therapy-related leukemia and...
MAINTENANCE INTENSIFICATION THERAPY | ORTHO-QUINONE | BENZENE | ONCOLOGY | SUSCEPTIBILITY | OXIDOREDUCTASE | C-609->T POLYMORPHISM | GLUTATHIONE-S-TRANSFERASE | ETOPOSIDE VP-16-213 | CANCER | MYELODYSPLASTIC SYNDROMES | NADH, NADPH Oxidoreductases - genetics | Electron Transport Complex I | Cytochrome P-450 CYP3A | Humans | Japan | Middle Aged | Genotype | Male | Risk | Polymorphism, Genetic | Codon | Glutathione Transferase - genetics | Gene Deletion | Myelodysplastic Syndromes - chemically induced | Alleles | Cytochrome P-450 Enzyme System - genetics | Adult | Female | Myelodysplastic Syndromes - genetics | Leukemia - chemically induced | Mixed Function Oxygenases - genetics | Leukemia - genetics | Leukemia, Myeloid, Acute - genetics
MAINTENANCE INTENSIFICATION THERAPY | ORTHO-QUINONE | BENZENE | ONCOLOGY | SUSCEPTIBILITY | OXIDOREDUCTASE | C-609->T POLYMORPHISM | GLUTATHIONE-S-TRANSFERASE | ETOPOSIDE VP-16-213 | CANCER | MYELODYSPLASTIC SYNDROMES | NADH, NADPH Oxidoreductases - genetics | Electron Transport Complex I | Cytochrome P-450 CYP3A | Humans | Japan | Middle Aged | Genotype | Male | Risk | Polymorphism, Genetic | Codon | Glutathione Transferase - genetics | Gene Deletion | Myelodysplastic Syndromes - chemically induced | Alleles | Cytochrome P-450 Enzyme System - genetics | Adult | Female | Myelodysplastic Syndromes - genetics | Leukemia - chemically induced | Mixed Function Oxygenases - genetics | Leukemia - genetics | Leukemia, Myeloid, Acute - genetics
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 06/2003, Volume 278, Issue 24, pp. 21930 - 21937
Members of the DTX ( D el t e x ) family act as Notch signaling modifiers and may also regulate transcription through interactions with specific transcription...
REGULATOR | DOMAIN | GENE | FINGER | RING | BIOCHEMISTRY & MOLECULAR BIOLOGY | BRCA1-BARD1 | MDM2 | Humans | Ubiquitin - metabolism | Molecular Sequence Data | Ligases - chemistry | Cell Nucleus - metabolism | Transfection | Time Factors | Cloning, Molecular | Dimerization | Carrier Proteins | Protein Structure, Tertiary | Recombinant Proteins - metabolism | Amino Acid Sequence | Cell Line | Signal Transduction | Glutathione Transferase - metabolism | Ligases - metabolism | Plasmids - metabolism | Blotting, Western | Precipitin Tests | Sequence Homology, Amino Acid | Ubiquitin-Protein Ligases | Cell Lineage | Two-Hybrid System Techniques | Animals | Proteins - metabolism | Protein Binding | Drosophila melanogaster
REGULATOR | DOMAIN | GENE | FINGER | RING | BIOCHEMISTRY & MOLECULAR BIOLOGY | BRCA1-BARD1 | MDM2 | Humans | Ubiquitin - metabolism | Molecular Sequence Data | Ligases - chemistry | Cell Nucleus - metabolism | Transfection | Time Factors | Cloning, Molecular | Dimerization | Carrier Proteins | Protein Structure, Tertiary | Recombinant Proteins - metabolism | Amino Acid Sequence | Cell Line | Signal Transduction | Glutathione Transferase - metabolism | Ligases - metabolism | Plasmids - metabolism | Blotting, Western | Precipitin Tests | Sequence Homology, Amino Acid | Ubiquitin-Protein Ligases | Cell Lineage | Two-Hybrid System Techniques | Animals | Proteins - metabolism | Protein Binding | Drosophila melanogaster
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2009, Volume 144, Issue 3, pp. 358 - 366
Summary Heat shock protein 90 (HSP90) is a molecular chaperone that stabilizes critical client proteins in multiple cancers. Gene expression profiling was...
client | AKT | IPI-504 | heat shock protein 90 | lymphoma | IPI‐504 | Client | Lymphoma | Heat shock protein 90 | MULTIPLE-MYELOMA | TARGET | HSP90 INHIBITOR | CYCLE ARREST | ANTITUMOR AGENT | GELDANAMYCIN | LEUKEMIA-CELLS | 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN | HEMATOLOGY | PHASE-I | HEAT-SHOCK-PROTEIN-90 INHIBITOR | Oligonucleotide Array Sequence Analysis | Apoptosis - drug effects | Humans | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | HSP90 Heat-Shock Proteins - analysis | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - genetics | Protein Isoforms - metabolism | Gene Deletion | Antineoplastic Agents - pharmacology | Lactams, Macrocyclic - therapeutic use | Proto-Oncogene Proteins c-akt - metabolism | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | RNA, Small Interfering - pharmacology | Protein Isoforms - analysis | Lactams, Macrocyclic - pharmacology | Benzoquinones - pharmacology | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Cell Line, Tumor | HSP90 Heat-Shock Proteins - metabolism | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Benzoquinones - therapeutic use | Doxorubicin - pharmacology | Proteins | Heat shock proteins | Lymphomas | Gene expression | Apoptosis
client | AKT | IPI-504 | heat shock protein 90 | lymphoma | IPI‐504 | Client | Lymphoma | Heat shock protein 90 | MULTIPLE-MYELOMA | TARGET | HSP90 INHIBITOR | CYCLE ARREST | ANTITUMOR AGENT | GELDANAMYCIN | LEUKEMIA-CELLS | 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN | HEMATOLOGY | PHASE-I | HEAT-SHOCK-PROTEIN-90 INHIBITOR | Oligonucleotide Array Sequence Analysis | Apoptosis - drug effects | Humans | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | HSP90 Heat-Shock Proteins - analysis | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - genetics | Protein Isoforms - metabolism | Gene Deletion | Antineoplastic Agents - pharmacology | Lactams, Macrocyclic - therapeutic use | Proto-Oncogene Proteins c-akt - metabolism | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | RNA, Small Interfering - pharmacology | Protein Isoforms - analysis | Lactams, Macrocyclic - pharmacology | Benzoquinones - pharmacology | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Cell Line, Tumor | HSP90 Heat-Shock Proteins - metabolism | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Benzoquinones - therapeutic use | Doxorubicin - pharmacology | Proteins | Heat shock proteins | Lymphomas | Gene expression | Apoptosis
Journal Article